SelectQuote Q1 FY2027: Revenue Falls 15% to $280M, Cash Drops to $14.3M
SLQT sits 44% above its 52-week low of $0.3.
Summary
SelectQuote's Q1 FY2027 revenue fell 15% to $280.0 million with a $20.3 million net loss, and cash dropped to $14.3 million while total debt rose to $385.8 million. The weak quarter lands ahead of the November 10 reverse-split vote aimed at curing the NYSE delisting notice.
Key Events · Earnings and Guidance · SLQT
-
Revenue Falls 15% to $280M
Total revenue was $280.0 million versus $328.8 million a year ago, with pharmacy revenue down 16% to $184.0 million and commissions and other services down 13% to $96.0 million.
-
Net Loss of $20.3M
Net loss was $20.3 million; after $20.2 million of preferred dividends and accretion, net loss attributable to common shareholders was $40.5 million, or $0.21 per share.
-
Cash Drops to $14.3M
Cash, cash equivalents and restricted cash fell to $14.3 million from $21.7 million at June 30, 2026, while total debt rose to $385.8 million from $370.2 million, including $21.0 million drawn on the revolver.
-
Senior Policies Down 22%
Approved policies fell 22% to 59,410 and Senior segment Adjusted EBITDA was $(12.3) million, though that was better than $(21.0) million a year ago on lower marketing spend.
Analysis · SLQT · Finance
Revenue fell 15% to $280.0 million and the company swung to a $20.3 million net loss, leaving $40.5 million attributable to common holders after $20.2 million of preferred dividends and accretion. Liquidity is the bigger issue: cash and restricted cash dropped to $14.3 million from $21.7 million, and total debt rose to $385.8 million as the company drew $21.0 million on its revolver. That thin cash cushion matters because shareholders vote November 10 on a reverse split to cure the NYSE delisting notice, and a DOJ False Claims Act case survived dismissal and remains unresolved. The one bright spot is Healthcare Services, where Adjusted EBITDA rose to $11.2 million from $7.2 million on cost cuts, while Senior's Adjusted EBITDA loss narrowed to $12.3 million from $21.0 million.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 32.4% of the 2221 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SLQT was trading at $0.43 on NYSE in the Finance sector, with a market capitalization of approximately $73.5M. The 52-week trading range was $0.30 to $2.17. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.